T. Goslinski et al. / Polyhedron 30 (2011) 1004–1011
1005
were studied for the substituent effects on their absorption spectra
2.1.3. 6-Ethoxycarbonylmethyl-4,5,6,7-tetrahydro-1,4,5,7-tetra-
in different solvents and on singlet oxygen generation.
methyl-1H-1,4-diazepine-2,3-dicarbonitrile (6)
NaH (60% in mineral oil, 0.068 g, 1.7 mmol) was suspended in
DMF (15 mL) and stirred for 30 min at ꢀ15 °C. Next, 5 (0.200 g,
0.763 mmol) in DMF (5 mL) was added over 30 min, and then the
mixture was stirred for another 30 min. (CH3)2SO4 (0.170 mL,
1.80 mmol) in DMF (2 mL) was added dropwise over 15 min at
ꢀ15 °C. The mixture was stirred for 2 h, poured into ice water
(50 mL) and then extracted with dichloromethane (3 ꢁ 50 mL).
The solvent was evaporated and the residual solid was chromato-
graphed (n-hexane–ethyl acetate 7:1 to 7:3) to give yellowish
crystals of meso compound 6 (0.180 g, 81%): Mp 69–70 °C, Rf 0.32
(n-hexane–ethyl acetate, 7:5). IR (neat) cmꢀ1: 2976, 2936, 2203,
1729, 1562, 1174, 1030. 1H NMR (400 MHz; CDCl3) dH, ppm: 4.18
(q, 2H, 3J = 7 Hz, CH2CH3), 3.50 (dq, 2H, 3J = 6 Hz, 2 ꢁ CHCH3),
2.93 (s, 6H, 2 ꢁ NCH3), 2.45 (m, 1H, CHCH2), 2.36 (d, 2H,
3J = 8 Hz, CH2CO), 1.29 (t, 3H, 3J = 7 Hz, CH2CH3), 1.19 (d, 6H,
3J = 7 Hz, 2 ꢁ CHCH3); 13C NMR (100 MHz; CDCl3) dC, ppm: 172.0
(CO), 115.1, 114.9, 61.0, 58.7, 39.4, 35.6, 32.7, 14.5, 14.2 (CH2CH3).
MS (EI) m/z: 290 [M]+Å. MS (ES): 313 [M+Na]+, 329 [M+K]+, 275
[MꢀCH3]ꢀ. HRMS (EI) m/z: 290.1737 (calc. for [M]+Å 290.1743).
Anal. Calc. for C15H22N4O2: C, 62.05; H, 7.64; N, 19.30. Found: C,
62.11; H, 7.67; N, 19.21%.
2. Experimental
2.1. Synthesis
The known compounds ethyl 3-acetyl-4-oxopentanoate (2a)
[16–18], ethyl 4-oxo-4-phenyl-3-(phenylcarbonyl)butanoate (2b)
[19], 5-methyl-7-phenyl-6H-1,4-diazepine-2,3-dicarbonitrile (9)
[20] and 5-[(E)-2-(4-methoxyphenyl)ethenyl]-7-phenyl-6H-1,4-
diazepine-2,3-dicarbonitrile (11a) [21] were synthesized according
to the literature procedures and their modifications.
2.1.1. 5,7-Dimethyl-6-ethoxycarbonylmethyl-6H-1,4-diazepine-2,3-
dicarbonitrile (4)
Diketone 2a (5.880 g, 31.60 mmol), diaminomaleonitrile
3
(3.420 g, 31.60 mmol) and oxalic acid dihydrate (0.200 g,
1.59 mmol) in benzene (63 mL) were refluxed under a Dean–Stark
receiver for 41 h. The solvent was then evaporated and the residual
solid was chromatographed (n-hexane–ethyl acetate, 7:3 to 7:4).
Crystallization from n-hexane–ethyl acetate gave yellowish crys-
tals of 4 (1.000 g, 12%): Mp 147–149 °C, Rf 0.42 (n-hexane–ethyl
acetate, 1:1). IR (neat) cmꢀ1: 2987, 2927, 2223, 1731, 1446, 1173,
1022, 948, 878. 1H NMR (400 MHz; CDCl3) dH, ppm: 4.26 (q, 2H,
3J = 7 Hz, CH2CH3), 3.27 (d, 2H, 3J = 8 Hz, CH2CO), 2.15 (s, 6H,
2 ꢁ CH3), 1.90 (t, 1H, 3J = 8 Hz, CH), 1.32 (t, 3H, 3J = 7 Hz, CH2CH3).
13C NMR (100 MHz; CDCl3) dC, ppm: 169.6 (CO), 152.6, 122.0,
114.2, 61.9 (OCH2), 53.8, 32.0, 22.2, 14.1 (CH2CH3). MS (EI)
m/z: 258 [M]+Å, 229 [MꢀCH3CH2]+, 213 [MꢀCH3CH2O]+, 185
[MꢀCH3CH2OCO]+, 171 [MꢀCH3CH2OCOCH2]+. MS (ES) m/z: 259
[M+H]+. HRMS (EI) m/z: 258.1116 (calc. for [M]+Å 258.1117). Anal.
Calc. for C13H14N4O2: C, 60.45; H, 5.46; N, 21.69. Found: C, 60.53;
H, 5.35; N, 21.55%.
Crystal data for 6: C15H22N4O2, M = 290.37, orthorhombic, Pca21,
a = 18.9315(7), b = 9.2846(3), c = 8.8695(3) Å, V = 1559.00(9) Å3,
Z = 4, Dc = 1.237 g cmꢀ3
,
l
(Mo K
T = 130 K, Xcalibur, Eos diffractometer, 2180 independent reflec-
tions, 1779 reflections with I > 2 (I), Rint = 0.025, hmax = 25.3°,
a
) = 0.09 mm–1, colorless prism,
r
R1(obs) = 0.033, wR2(all) = 0.068, 195 parameters, 1 restraint.
2.1.4. Tetrakis(6-pentoxycarbonylmethyl-4,5,6,7-tetrahydro-1,4,5,7-
tetramethyl-1H-1,4-diazepino)[2,3-b;20,30-g;200,300-l;2000,3000-q]porphy-
razinatozinc(II) (7)
Diazepine
6 (0.196 g, 0.676 mmol), zinc acetate (0.062 g,
0.34 mmol), pentanol (2 mL) and DBU (0.100 mL, 0.676 mmol)
were added together and stirred for 16 h at 130 °C. The solvent
was then evaporated with toluene and the residual oil was chro-
matographed three times (n-hexane–ethyl acetate 7:3 to 1:1) to
give a blue unseparable mixture of the diastereoisomeric porphyr-
azines 7 (0.017 g, 7%): Rf 0.21 (n-hexane–ethyl acetate 7:3). UV–Vis
Crystal data for 4: C13H14N4O2, M = 258.28, monoclinic, P21/c,
a = 9.0074(2), b = 13.4610(3), c = 11.5446(3) Å, b = 108.826(3)°,
V = 1324.88(6) Å3, Z = 4, Dc = 1.295 g cmꢀ3
,
l
(Mo K
colorless blocks, T = 173 K, OD Xcalibur 3 diffractometer, 4423 inde-
pendent reflections, 3398 reflections with I > 2 (I), Rint = 0.022,
a ,
) = 0.09 mmꢀ1
r
hmax = 32.3°, R1(obs) = 0.039, wR2(all) = 0.121, 174 parameters.
(dichloromethane) kmax, nm (log
e): 348 (4.47), 560 (4.33). IR (neat)
cmꢀ1 2928, 1733, 1578, 1465, 1377, 1275, 1167. 1H NMR
:
2.1.2. 5,7-Dimethyl-6-ethoxycarbonylmethyl-4,5,6,7-tetrahydro-1H-
1,4-diazepine-2,3-dicarbonitrile (5)
(500 MHz; d5-pyridine) dH, ppm: 4.26 (overlapped, 8H, 8 ꢁ CHCH3),
4.24 (s, 24H, 8 ꢁ NCH3), 4.17 (t, 3J = 7 Hz, 8H, 4 ꢁ OCH2), 3.16 (m,
4H, 4 ꢁ CHCH2), 2.81 (m, 8H, 4 ꢁ CH2CO), 1.56 (m, 8H,
4 ꢁ OCH2CH2), 1.52 (m, 24H, 8 ꢁ CHCH3), 1.22 (m, 16H,
4 ꢁ CH2CH2CH3), 0.79 (t, 3J = 6 Hz, 12H, 4 ꢁ CH2CH3). 13C NMR
(126 MHz; d5-pyridine) dC, ppm: 173.6 (CO), 152.1, 152.0, 136.7,
136.3, 64.5, 60.5, 41.9, 38.5, 32.3, 28.4, 28.0, 22.2, 16.7, 13.8
(CH2CH3). MS (MALDI TOF) m/z 1394 [M + H]+.
NaBH4 (0.204 g, 5.40 mmol) was added in three portions to a
suspension of diazepine 4 (0.664 g, 2.57 mmol) in methanol
(20 mL) at ꢀ5 °C over 45 min. The mixture was then stirred for an-
other 1.5 h at room temperature. The solvent was evaporated and
the residual solid was diluted with water (20 mL) and extracted
with ethyl acetate (total amount 250 mL). Chromatography (n-hex-
ane–ethyl acetate, 7:1 to 1:1) gave diazepine 5 (0.607 g, 90%): Mp
149–150 °C, Rf 0.82 (n-hexane–ethyl acetate, 2:3). IR (neat) cmꢀ1
:
2.1.5. (6-Pentoxycarbonylmethyl-4,5,6,7-tetrahydro-1,4,5,7-tetra-
3342, 2984, 2209, 1730, 1536, 1460, 1277, 1175. 1H NMR
(300 MHz; CDCl3) dH, ppm: 4.13 (q, 2H, 3J = 7 Hz, CH2CH3), 3.48
(bs, 2H, 2 ꢁ NH), 2.99 (q, 2H, 3J = 6 Hz, 2 ꢁ NHCH), 2.22 (s, 3H,
CHCH2CO), 1.26 (t, 3H, 3J = 7 Hz, CH2CH3), 1.22 (d, 6H, 3J = 7 Hz,
2 ꢁ CHCH3). 1H NMR (400 MHz; DMSO-d6) dH, ppm: 5.95 (s, 2H,
2 ꢁ NH), 4.04 (q, 2H, 3J = 7 Hz, CH2CH3), 2.88 (q, 2H, 3J = 6 Hz,
2 ꢁ NHCH), 2.03 (overlapped, 2H, CH2CO), 2.01 (overlapped, 1H,
CHCH2), 1.17 (t, 3H, 3J = 7 Hz, CH2CH3), 1.08 (d, 6H, 3J = 6 Hz,
2 ꢁ CHCH3). 13C NMR (75 MHz; CDCl3) dC, ppm: 173.6 (CO),
116.4, 109.4, 60.8, 58.3, 47.1, 26.0, 20.7, 14.1 (CH2CH3). 13C NMR
(100 MHz; DMSO-d6) dC, ppm: 173.3 (CO), 117.2, 107.9, 60.0,
57.3, 48.0, 25.8, 19.9, 14.0 (CH2CH3). MS (ES) m/z: 261 [MꢀH]ꢀ,
285 [M+Na]+. Anal. Calc. for C13H18N4O2: C, 59.53; H, 6.92; N,
21.36. Found: C, 59.32; H, 6.56; N, 21.17%.
methyl-1H-1,4-diazepino)[2,3-q]tribenzo[b,g,l]porphyrazinatozinc(II)
(8)
Diazepine
6 (0.102 g, 0.350 mmol), phthalonitrile (0.448 g,
3.50 mmol), zinc acetate (0.353 g, 1.92 mmol) and DBU
(0.575 mL, 3.85 mmol) were added to pentanol (3 mL) and refluxed
for 24 h. The reaction mixture was cooled to room temperature and
the solvent was evaporated with toluene (2 ꢁ 50 mL). The residual
oil was chromatographed twice (n-hexane–ethyl acetate 7:5 and n-
hexane–ethyl acetate 7:1 to 7:1.5) to give the light blue porphyr-
azine 8 (0.036 g, 13%): Rf 0.70 (n-hexane–ethyl acetate, 7:5). UV–
Vis (DMSO): kmax, nm (log e
): 349 (4.21), 667 (4.31). 1H NMR
(400 MHz; d5-pyridine) dH, ppm: 9.75 (m, 4H, ArH), 9.54 (d, 2H,
3J = 6 Hz, ArH), 8.18 (m, 6H, ArH), 4.51 (s, 6H, 2 ꢁ NCH3), 4.38
(dq, 2H, 3J = 7 Hz, 2 ꢁ CHCH3), 4.18 (t, 2H, 3J = 7 Hz, OCH2), 3.26